-
316
0
[UpHealth Inc吧] Current report, items 2.02, 4.02, 7.01, and 9.01
UpHealth Inc
03-30 20:38
03-30 20:38
-
885
0
[安博科-匹兹堡吧] Current report, items 7.01 and 9.01
安博科-匹兹
03-30 20:38
03-30 20:38
-
372
0
[掌门教育吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
掌门教育资讯
03-30 20:38
03-30 20:38
-
378
0
[Epizyme Inc吧] Other definitive proxy statements
Epizyme Inc
03-30 20:38
03-30 20:38
-
284
0
[格林布赖尔吧] Current report, items 5.02, 5.03, 7.01, and 9.01
格林布赖尔资
03-30 20:38
03-30 20:38
-
181
0
[Arhaus Inc-A吧] Annual report [Section 13 and 15(d), not S-K Item 405]
Arhaus Inc-A
03-30 20:38
03-30 20:38
-
440
0
[大全新能源吧] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
大全新能源资
03-30 20:38
03-30 20:38
-
209
0
[KORE Group Holdings Inc吧] Prospectus [Rule 424(b)(3)]
KORE Group H
03-30 20:38
03-30 20:38
-
301
0
[RedHill Biopharma Ltd ADR吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
RedHill Biop
03-30 20:38
03-30 20:38
-
399
0
[Galiano Gold Inc吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Galiano Gold
03-30 20:38
03-30 20:38
-
408
0
[克罗格吧] Additional definitive proxy soliciting materials filed by non-management and Ru
克罗格资讯
03-30 20:38
03-30 20:38
-
173
0
[Vyant Bio Inc吧] Annual report [Section 13 and 15(d), not S-K Item 405]
Vyant Bio In
03-30 20:38
03-30 20:38
-
341
0
[Mesoblast Ltd ADR吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Mesoblast Lt
03-30 20:37
03-30 20:37
-
171
0
[Alaunos Therapeutics Inc吧] Annual report [Section 13 and 15(d), not S-K Item 405]
Alaunos Ther
03-30 20:37
03-30 20:37
-
186
0
[Alaunos Therapeutics Inc吧] Current report, items 2.02 and 9.01
Alaunos Ther
03-30 20:37
03-30 20:37
-
434
0
[Absolute Software Corp吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Absolute Sof
03-30 20:37
03-30 20:37
-
319
0
[Western New England Bancorp Inc吧] Other definitive proxy statements
Western New
03-30 20:37
03-30 20:37
-
410
0
[Partner Communications Co Ltd A吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Partner Comm
03-30 20:37
03-30 20:37
-
1224
0
[兰亭集势吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
兰亭集势资讯
03-30 20:37
03-30 20:37
-
831
0
[宝尊电商吧] Securities to be offered to employees in employee benefit plans
宝尊电商资讯
03-30 20:37
03-30 20:37
-
219
0
[Enfusion Inc-A吧] Annual report [Section 13 and 15(d), not S-K Item 405]
Enfusion Inc
03-30 20:19
03-30 20:19
-
456
0
[爱立信吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
爱立信资讯
03-30 20:17
03-30 20:17
-
349
0
[欧文斯伊利诺斯玻璃吧] Other definitive proxy statements
欧文斯伊利诺
03-30 20:17
03-30 20:17
-
321
0
[Guess Inc吧] Non-management revised preliminary proxy soliciting materials, contested and ot
Guess Inc资
03-30 20:17
03-30 20:17
-
762
0
[安博科-匹兹堡吧] Prospectuses and communications, business combinations
安博科-匹兹
03-30 20:17
03-30 20:17
-
789
0
[梅西百货吧] Current report, items 5.02 and 9.01
梅西百货资讯
03-30 20:17
03-30 20:17
-
409
0
[艾睿电子吧] Additional definitive proxy soliciting materials and Rule 14(a)(12) material
艾睿电子资讯
03-30 20:17
03-30 20:17
-
402
0
[艾睿电子吧] Other definitive proxy statements
艾睿电子资讯
03-30 20:17
03-30 20:17
-
387
0
[Data I/O Corp吧] Current report, item 7.01
Data I/O Cor
03-30 20:17
03-30 20:17
-
179
0
[KORE Group Holdings Inc吧] Current report, items 2.02 and 9.01
KORE Group H
03-30 20:17
03-30 20:17
-
330
0
[Core & Main Inc-A吧] Annual report [Section 13 and 15(d), not S-K Item 405]
Core & Main
03-30 20:17
03-30 20:17
-
512
0
[Immunovant Inc吧] Current report, items 7.01 and 9.01
Immunovant I
03-30 20:16
03-30 20:16
-
399
0
[INmune Bio Inc吧] Current report, items 8.01 and 9.01
INmune Bio I
03-30 20:16
03-30 20:16
-
482
0
[Rubius Therapeutics Inc吧] Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Rubius Thera
03-30 20:16
03-30 20:16
-
789
0
[佳能吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
佳能资讯
03-30 20:16
03-30 20:16
-
369
0
[Centogene NV吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Centogene NV
03-30 20:16
03-30 20:16
-
337
0
[YD Bio Ltd吧] Current report, items 8.01 and 9.01
YD Bio Ltd资
03-30 20:16
03-30 20:16
-
367
0
[Orchard Therapeutics plc ADR吧] Current report, items 2.02 and 9.01
Orchard Ther
03-30 20:16
03-30 20:16
-
462
0
[Rubius Therapeutics Inc吧] Other definitive proxy statements
Rubius Thera
03-30 20:16
03-30 20:16
-
1000
0
[Sabre Corp吧] Current report, item 7.01
Sabre Corp资
03-30 20:16
03-30 20:16
-
185
0
[InPoint Commercial Real Estate吧] Current report, item 8.01
InPoint Comm
03-30 20:16
03-30 20:16
-
409
0
[Vicinity Motor Corp吧] Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
Vicinity Mot
03-30 20:16
03-30 20:16
-
557
0
[AtaiBeckley Inc吧] Current report, items 2.02 and 9.01
AtaiBeckley
03-30 20:16
03-30 20:16
-
339
0
[SiteOne Landscape Supply Inc吧] Other definitive proxy statements
SiteOne Land
03-30 20:16
03-30 20:16
-
431
0
[Epizyme Inc吧] Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Epizyme Inc
03-30 20:16
03-30 20:16
-
789
0
[BiomX Inc吧] Current report, items 2.02, 7.01, and 9.01
BiomX Inc资
03-30 20:16
03-30 20:16
-
351
0
[Orchard Therapeutics plc ADR吧] Annual report [Section 13 and 15(d), not S-K Item 405]
Orchard Ther
03-30 20:16
03-30 20:16
-
584
0
[North Mountain Merger Corp-A吧] Prospectuses and communications, business combinations
North Mounta
03-30 20:16
03-30 20:16
-
378
0
[Sol-Gel Technologies Ltd吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Sol-Gel Tech
03-30 20:16
03-30 20:16
-
316
0
[UpHealth Inc吧] Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KS
UpHealth Inc
03-30 20:16
03-30 20:16
-
852
0
[Churchill Downs Inc吧] Current report, items 7.01, 8.01, and 9.01
Churchill Do
03-30 20:16
03-30 20:16
-
348
0
[SiteOne Landscape Supply Inc吧] Additional definitive proxy soliciting materials and Rule 14(a)(12) material
SiteOne Land
03-30 20:16
03-30 20:16
-
784
0
[佳能吧] Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction
佳能资讯
03-30 20:16
03-30 20:16
-
329
0
[Clear Secure Inc-A吧] Securities to be offered to employees in employee benefit plans
Clear Secure
03-30 20:16
03-30 20:16
-
468
0
[VYNE Therapeutics Inc吧] Current report, items 8.01 and 9.01
VYNE Therape
03-30 20:16
03-30 20:16
-
173
0
[KORE Group Holdings Inc吧] Prospectus [Rule 424(b)(3)]
KORE Group H
03-30 20:16
03-30 20:16
-
318
0
[iRadimed Corp吧] Statement of changes in beneficial ownership of securities
iRadimed Cor
03-30 20:16
03-30 20:16
-
393
0
[Endava plc ADR吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
Endava plc A
03-30 20:16
03-30 20:16
-
313
0
[ironSource Ltd-A吧] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
ironSource L
03-30 20:16
03-30 20:16
-
328
0
[VectivBio Holding AG吧] Report of foreign issuer [Rules 13a-16 and 15d-16]
VectivBio Ho
03-30 20:16
03-30 20:16
-
404
0
[Fidus Investment Corp吧] Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Fidus Invest
03-30 20:16
03-30 20:16
-
374
0
[Axcella Health Inc吧] Current report, items 2.02 and 9.01
Axcella Heal
03-30 20:16
03-30 20:16
-
880
0
[MSC Industrial Direct Co Inc-A吧] Current report, items 2.02 and 9.01
MSC Industri
03-30 20:16
03-30 20:16
-
304
0
[Redwood Trust Inc吧] Other definitive proxy statements
Redwood Trus
03-30 20:10
03-30 20:10
-
176
0
[英特尔吧] Other definitive proxy statements
英特尔资讯
03-30 20:10
03-30 20:10
-
145
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
151
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
132
0
[摩根士丹利吧] Prospectus [Rule 424(b)(2)]
摩根士丹利资
03-30 20:06
03-30 20:06
-
149
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
123
0
[花旗集团吧] Prospectus [Rule 424(b)(2)]
花旗集团资讯
03-30 20:06
03-30 20:06
-
127
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
324
0
[Redwood Trust Inc吧] Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Redwood Trus
03-30 20:06
03-30 20:06
-
152
0
[摩根大通吧] Prospectus [Rule 424(b)(2)]
摩根大通资讯
03-30 20:06
03-30 20:06
-
161
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
125
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
121
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
333
0
[SilverBow Resources Inc吧] Other definitive proxy statements
SilverBow Re
03-30 20:06
03-30 20:06
-
127
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
129
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
-
132
0
[摩根士丹利吧] Filing under Securities Act Rules 163/433 of free writing prospectuses
摩根士丹利资
03-30 20:06
03-30 20:06
共有帖子数 4268241 篇